Hook and thesis
If you wanted exposure to the commercial space theme but missed the big run earlier this year, today offers a cleaner entry. Intuitive Machines (LUNR) has retraced sharply from its 52-week high of $46.75 to the mid-teens. That drop is painful, but it leaves a capital-efficient way to own a company with a deep, converting backlog, multiple NASA mission catalysts, and a production ramp that can materially re-rate revenue.
My base case: buy a tactical long at the current setup for a measured, event-driven trade that leans on backlog conversion and mission execution over the next 3-6 months. This is not a buy-and-forget; it is a trade that recognizes both the upside tied to execution and the downside from fixed-price mission risk and negative cash flow.
What the company does and why the market should care
Intuitive Machines is a Houston-based space infrastructure and services company that builds lunar landers and related systems to support cislunar and deep space commerce. The business model combines government and commercial contracts to deliver spacecraft, payload delivery and specialized services for lunar missions. Institutional and retail interest has been driven by tangible mission manifests and NASA partnerships - practical proof that the firm is not a concept play but an operating aerospace contractor.
Key fundamental drivers
The core driver is backlog conversion. The company ended Q2 with a record $1.8 billion backlog after booking $920 million in awards in the quarter. That backlog should drive substantial revenue growth as contracts convert into deliveries and launches. Management guided that 25-30% of backlog could convert to 2026 revenue, and the firm gave a full-year revenue range of $900 million to $1.0 billion for 2026. Those are the numbers that underpin upside — if Intuitive Machines actually converts awards into recognized revenue at scale and avoids major cost overruns.
What the recent numbers tell us
Recent reported figures show the business is scaling: Q2 revenue came in at $206.2 million, up 310% year-over-year, a clear signal that sales are expanding rapidly. At the same time, profitability is not yet solved — the company remains unprofitable on a GAAP basis and posted negative free cash flow. Free cash flow in the latest reporting stands at approximately -$187.8 million, and quarterly cash burn figures have been highlighted by analysts at roughly -$59.8 million per quarter. That combination of strong top-line growth and negative cash flow is the dual nature of the story: growth with execution and liquidity risk.
Valuation framing
Market capitalization sits around $3.15 billion. On common valuation metrics the stock looks expensive on a current-sales basis: price-to-sales is roughly 4.5x and enterprise-value-to-sales is approximately 4.48x. Those multiples are above many industrial aerospace contractors but reflect investor willingness to pay for growth and unique lunar positioning. Against the $1.8 billion backlog, market cap is not unreasonable: the backlog alone is on the same order as the market capitalization, and management expects a sizable portion to convert this year. Still, margins and execution are the linchpins. If the company can hold to its $900M-$1.0B revenue guidance and reduce the cash burn trajectory, the multiple could compress to more reasonable levels as revenue scales into the numerator of valuation math.
Technical and market context
From a technical lens, LUNR is in a corrective phase: the 9-day EMA sits at $14.46 and the 21-day EMA at $15.17, while the 50-day EMA remains higher at $16.71. RSI is roughly 36, which suggests the stock is nearer to oversold territory than overbought. Volume on recent sessions is below the two-week average, but short interest remains material with short interest reports showing 35.5 million shares and days-to-cover fluctuating in the 2.6-4.4 range depending on the average volume period used. Those dynamics mean the stock can move quickly in either direction around news events.
Catalysts to watch (2-5)
- Scheduled NASA missions and public progress updates on IM lander flights - successful mission milestones would be the clearest re-rating events.
- Quarterly results and updated guidance that show backlog-to-revenue conversion accelerating toward the $900M-$1B target for 2026.
- Further contract awards and additions to the $1.8B backlog; incremental awards reduce perceived revenue risk and can lift the multiple.
- Improvements in free cash flow or explicit moves toward profitable unit economics (cost control, higher-margin commercial work).
Trade plan (actionable)
This is a tactical, event-driven long. I think the right horizon is long term (180 trading days) to allow for mission cadence and backlog conversion to play out, but the position should be managed actively around milestone noise.
| Parameter | Value |
|---|---|
| Entry price | $13.50 |
| Stop loss | $11.00 |
| Target price | $22.00 |
| Time horizon | Long term (180 trading days) |
Rationale: entry around $13.50 captures the current weakness and gives some buffer to the market price. The $11.00 stop protects capital if mission execution or a broad reset of space sentiment triggers another leg down. The $22 target is reachable if management converts a significant portion of backlog into revenue and shows improving margins, with upside from renewed bullishness around NASA mission success and further contract wins.
Why this trade makes sense now
Two things line up: first, the company is no longer a pre-revenue concept. It is booking real revenue at scale ($206.2M in Q2) and reporting a sizable backlog ($1.8B). Second, the stock has retraced substantially from its highs, compressing downside for patient buyers who accept execution risk. That combination - tangible business progress and a lower price - creates an asymmetric risk/reward for a tactical long.
Counterargument
One reasonable objection: the stock is still richly priced relative to current cash flows and profitability. Price-to-sales north of 4x and a negative free cash flow profile mean that any material execution hiccup or charge (like the IM-4 mission $14.7M charge noted in recent results) can drive the share price materially lower. If you believe fixed-price lunar missions remain too risky or that backlog conversion will slip, it is rational to stay sidelined until clearer execution proof points appear.
Risks (at least four)
- Execution risk on fixed-price missions - overruns, delays or mission failures can trigger big charges and damage credibility.
- Cash burn and liquidity risk - negative free cash flow (~-$187.8M reported) and quarterly cash burn create the need for capital if revenue conversion slips.
- Government concentration - a heavy reliance on NASA and public awards creates timing and political risk around funding flows.
- Valuation sensitivity - the stock trades at a premium on sales; sentiment can swing violently if growth disappoints.
- Competitive and technological risk - other lunar vendors and shifts in launch economics could compress margins or change contract dynamics.
What would change my mind
I would become more bullish if management demonstrates consistent, quarter-to-quarter reductions in cash burn and the company reports consecutive quarters where backlog conversion exceeds the low end of guidance. Conversely, I would lower the target or move to a cautious stance if the company issues a large charge from a mission failure, misses its $900M-$1B revenue range materially, or if liquidity metrics require dilutive capital raises at unfavorable prices.
Conclusion
This is a high-risk, high-reward trade: buy a tactical long at $13.50 with a $11 stop and $22 target, and give the trade about 180 trading days to play out around mission execution and backlog conversion. If Intuitive Machines executes, upside is meaningful from here; if it stumbles, downside can be sharp. Position sizing matters - treat this as a spec allocation inside a diversified portfolio rather than a core holding.
Key data points referenced: $1.8B backlog, Q2 revenue $206.2M (+310% YoY), free cash flow roughly -$187.8M, market cap roughly $3.15B, price-to-sales ~4.5x, 52-week high $46.75, current price near $13.78.